Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.
Reporting Cycle
10 working days
Clinical Application Overview
1. Chromosomal Abnormalities Screening: Screen for chromosomal abnormalities in children with developmental issues, intellectual disabilities, multiple malformations, and other illnesses. Provide guidance for disease confirmation and treatment.
2. Genetic Causes Identification: Identify genetic causes of recurrent miscarriage and infertility. Offer follow-up fertility guidance and recommendations.
What Is Chromosome Karyotype Analysis?April 4, 2023Chromosome karyotype analysis is a technique that traditionally involves observing the morphology of chromosomes. In recent years, fluorescence in situ hybridization technology has been used to detect...view
Alcohol Metabolite Test Reveals Your True Drinking CapacityNovember 13, 2024Significance of Alcohol Metabolite TestIndicates an individual's ability to metabolize and detoxify alcohol, guiding reasonable and healthy drinkingReveals a high-risk tendency for major diseasesM...view
Chromosome Microarray (CMA) Detection 2.0 (4)August 27, 2024Testing ContentDetection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.Testing MethodMicroarray Chip methodCMA ChipSample RequirementsMiscarriage ...view
Basic Performance of In Vitro Diagnostic Reagent ProductsMarch 9, 20231. Blank IVD in vitro diagnostic reagentsThe reagent blank can be understood as the value detected when the content of the substance to be tested is the theoretical zero value. The general practice is...view
Development Status and Future of in Vitro Diagnostic TechnologyDecember 15, 2022In vitro diagnostic technology refers to products and services that obtain relevant clinical diagnostic information by testing samples of the body including blood, body fluids, and tissues outside the...view